MedPath

APO-AMITRIPTYLINE 25MG TABLET

Registration Number: MAL19984711ARZ

Approved
Approval ID

43265e473623d30c

Registration Number

MAL19984711ARZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

500 TabletsAvailable
Package Size: 500 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

AMITRIPTYLLINE HYDROCHLORIDEActive
Monograph: amitriptylline hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-AMITRIPTYLINE 25MG TABLET - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform